Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 351.22%19.53M | 22.82%4.91M | 24.90%4.34M | -8.36%15.7M | -12.73%3.9M | -1.53%4.33M | 4M | 3.48M | 17.13M | 4.46M |
| Operating revenue | 351.22%19.53M | 21.43%4.19M | 24.90%4.34M | -8.36%15.7M | -12.73%3.9M | -1.53%4.33M | --3.45M | --3.48M | --17.13M | --4.46M |
| Cost of revenue | 481.89%13.85M | 24.27%2.94M | 20.68%2.53M | -10.69%9.42M | -4.97%2.57M | -14.07%2.38M | 2.37M | 2.1M | 10.54M | 2.71M |
| Gross profit | 191.55%5.68M | 20.71%1.97M | 31.30%1.81M | -4.63%6.28M | -24.70%1.32M | 19.84%1.95M | 1.63M | 1.38M | 6.59M | 1.75M |
| Operating expense | 624.86%5.85M | 25.94%1.37M | 90.28%1.23M | 37.55%4.37M | 120.55%1.82M | 11.67%806.54K | -5.73%1.09M | 168.52%646.5K | -58.37%3.17M | 447.76%826.29K |
| Selling and administrative expenses | 697.68%5.8M | 31.23%1.29M | 103.64%1.16M | 44.93%3.85M | 174.74%1.57M | 13.61%727.33K | 518.21%982.15K | 136.70%569.87K | 559.47%2.65M | 277.94%570.12K |
| -Selling and marketing expense | 9.11%301.46K | -6.92%339.19K | 42.60%321K | 70.92%479.9K | 48.54%-385.91K | -2.62%276.29K | --364.41K | --225.11K | --280.77K | ---749.91K |
| -General and administrative expense | 1,119.48%5.5M | 53.73%949.66K | 143.50%839.5K | 41.86%3.37M | 47.89%1.95M | 26.52%451.04K | 288.83%617.74K | 43.20%344.77K | 489.69%2.37M | 775.07%1.32M |
| Research and development costs | -43.83%44.49K | -21.93%84.73K | -9.05%69.69K | 5.18%347.64K | 26.19%83.28K | -3.45%79.21K | --108.52K | --76.62K | --330.51K | --66K |
| Depreciation amortization depletion | ---- | ---- | ---- | -24.05%39.9K | ---- | ---- | ---- | ---- | --52.53K | ---- |
| -Depreciation and amortization | ---- | ---- | ---- | -24.05%39.9K | ---- | ---- | ---- | ---- | --52.53K | ---- |
| Other taxes | ---- | ---- | ---- | 4.35%129K | ---- | ---- | ---- | ---- | --123.63K | ---- |
| Other operating expenses | ---- | ---- | ---- | -72.76%3.82K | --3.82K | --44.58M | ---- | ---- | -99.81%14.02K | ---- |
| Operating profit | -114.51%-165.66K | 10.16%595.05K | -20.54%584.6K | -43.86%1.92M | -154.05%-501.53K | 26.37%1.14M | 146.69%540.16K | 405.58%735.71K | 144.76%3.41M | 715.10%927.87K |
| Net non-operating interest income (expenses) | -1,275.87%-1.57M | -70.01%-191.45K | -24.69%-167.39K | -43.87%-506.16K | -24.94%-145.4K | 0.95%-113.9K | -108.67%-112.62K | -111.08%-134.24K | -120.97%-351.83K | -112.01%-116.37K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | -98.21%23.23K | -97.32%32.52K | ---- | ---- |
| Non-operating interest expense | 1,275.87%1.57M | 70.01%191.45K | 24.69%167.39K | 35.02%411.72K | -26.67%50.96K | -0.95%113.9K | --112.62K | --134.24K | --304.95K | --69.49K |
| Total other finance cost | ---- | ---- | ---- | 101.44%94.44K | ---- | ---- | ---- | ---- | --46.88K | ---- |
| Other net income (expenses) | 123.82%10.65M | -17,831.68%-21.84M | 6,179.13%10.1M | -14,937.74%-48.3M | -2,457.41%-3.86M | -35,401.89%-44.72M | -74.26%123.17K | 328.73%160.77K | 95.74%-321.19K | 95.33%-151.04K |
| Gain on sale of security | 310.09%295.27K | -17,831.68%-21.84M | 6,179.13%10.1M | -844.51%-3.68M | -1,640.85%-3.83M | -210.95%-140.55K | --123.17K | --160.77K | ---389.95K | ---219.81K |
| Special income (charges) | --0 | ---- | ---- | -64,980.11%-44.62M | -152.66%-36.21K | ---44.58M | ---- | ---- | --68.77K | --68.77K |
| -Less:Other special charges | ---- | ---- | ---- | --44.58M | --0 | --44.58M | ---- | ---- | ---- | ---- |
| -Less:Write off | ---- | ---- | ---- | 152.66%36.21K | ---- | ---- | ---- | ---- | ---68.77K | ---- |
| Other non-operating income (expenses) | --10.36M | ---- | ---- | ---- | ---- | ---- | -606.94%-2.43M | -4,453.23%-1.63M | ---- | ---- |
| Income before tax | 120.42%8.92M | -3,992.44%-21.44M | 1,279.14%10.51M | -1,811.31%-46.89M | -782.82%-4.51M | -4,873.75%-43.69M | -11.33%550.71K | -24.44%762.24K | 120.31%2.74M | 127.30%660.46K |
| Income tax | 186.91%681.43K | 76.27%219.36K | 53.54%247.99K | -14.20%457.2K | -157.09%-66.27K | -20.13%237.51K | -51.80%124.45K | 161.51K | 532.85K | -25.78K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 118.75%8.24M | -5,180.31%-21.66M | 1,608.65%10.26M | -2,245.18%-47.35M | -747.51%-4.44M | -7,209.39%-43.93M | 17.47%426.26K | -40.45%600.72K | 116.36%2.21M | 128.36%686.23K |
| Net income continuous operations | 118.75%8.24M | -5,180.31%-21.66M | 1,608.65%10.26M | -2,245.18%-47.35M | -747.51%-4.44M | -7,209.39%-43.93M | 17.47%426.26K | -40.45%600.72K | 116.36%2.21M | 128.36%686.23K |
| Noncontrolling interests | 193.78K | 0 | ||||||||
| Net income attributable to the company | 118.31%8.05M | -5,180.31%-21.66M | 1,608.65%10.26M | -2,245.18%-47.35M | -747.51%-4.44M | -7,209.36%-43.93M | 17.47%426.26K | -40.45%600.72K | 116.36%2.21M | 128.36%686.23K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 118.31%8.05M | -5,180.31%-21.66M | 1,608.65%10.26M | -2,245.18%-47.35M | -747.51%-4.44M | -7,209.36%-43.93M | 17.47%426.26K | -40.45%600.72K | 116.36%2.21M | 128.36%686.23K |
| Diluted earnings per share | 105.83%1.19 | -1,804.55%-3.75 | 490.98%7.21 | -1,553.57%-16.28 | -319.98%-0.7699 | -6,683.87%-20.41 | 69.23%0.22 | 248.57%1.22 | 117.89%1.12 | 131.25%0.35 |
| Basic earnings per share | 105.83%1.19 | -1,804.55%-3.75 | 490.98%7.21 | -1,553.57%-16.28 | -319.98%-0.7699 | -6,683.87%-20.41 | 69.23%0.22 | 248.57%1.22 | 117.89%1.12 | 131.25%0.35 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.